Understanding how immune cells adapt in tissues to fight infections and prevent autoimmunity

Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-11012784

This study is looking at how special immune cells called dendritic cells work in different parts of the body, like the skin and lungs, to help fight off infections while keeping us safe from harm, with the goal of finding better ways to improve vaccines and treat illnesses like cancer and viral infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11012784 on NIH RePORTER

What this research studies

This research investigates how dendritic cells (DCs), which are crucial for immune responses, adapt in different tissues like the skin, lungs, and gut to effectively detect pathogens while preventing damage to the body. The study aims to uncover the mechanisms that allow these cells to balance their roles in immunity and self-tolerance. By exploring how DCs differentiate and function in various environments, the research seeks to improve strategies for vaccination and treatment of viral infections and cancer. Patients may benefit from insights gained about enhancing immune responses through better-targeted therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with conditions that affect immune responses, such as cancer patients or those with viral infections.

Not a fit: Patients with stable, non-immune related conditions may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved immunization strategies and therapies for viral infections and cancer.

How similar studies have performed: Previous research has shown promise in understanding immune cell adaptations, indicating potential for success in this novel approach.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.